Connable Office Inc’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,261
Closed -$713K 202
2023
Q2
$713K Sell
3,261
-70
-2% -$15.6K 0.1% 102
2023
Q1
$729K Sell
3,331
-1,862
-36% -$404K 0.11% 102
2022
Q4
$1.08M Buy
5,193
+68
+1% +$14.9K 0.15% 87
2022
Q3
$1.12M Sell
5,125
-1,619
-24% -$368K 0.18% 81
2022
Q2
$1.41M Hold
6,744
0.22% 77
2022
Q1
$1.64M Buy
6,744
+670
+11% +$162K 0.22% 77
2021
Q4
$1.58M Sell
6,074
-3
-0% -$778 0.2% 87
2021
Q3
$1.6M Sell
6,077
-311
-5% -$85K 0.23% 79
2021
Q2
$1.57M Sell
6,388
-356
-5% -$74.8K 0.22% 81
2021
Q1
$1.31M Buy
6,744
+429
+7% +$86K 0.19% 83
2020
Q4
$1.34M Sell
6,315
-276
-4% -$55K 0.21% 82
2020
Q3
$1.13M Sell
6,591
-545
-8% -$101K 0.21% 80
2020
Q2
$1.37M Sell
7,136
-244
-3% -$39.9K 0.27% 67
2020
Q1
$1.09M Sell
7,380
-946
-11% -$151K 0.26% 67
2019
Q4
$1.29M Sell
8,326
-236
-3% -$34K 0.22% 75
2019
Q3
$1.16M Hold
8,562
0.21% 77
2019
Q2
$1.04M Sell
8,562
-593
-6% -$65.7K 0.19% 84
2019
Q1
$952K Buy
+9,155
New +$945K 0.18% 82

Other funds holding RMD

Connable Office Inc's RMD Position: Q3 2023 in Review

Connable Office Inc sold out of ResMed (RMD) in Q3 2023, closing a stake of 3,261 shares — an estimated $713K sold.

Connable Office Inc first reported a position in RMD in Q1 2019 and held it in 18 quarters. The position peaked at $1.64M in Q1 2022. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Connable Office Inc reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Connable Office Inc sold 3,261 ResMed shares in Q3 2023, an estimated $713K.
  • Connable Office Inc first reported a position in ResMed in Q1 2019 and held it in 18 quarters.
  • Connable Office Inc's ResMed position peaked at $1.64M in Q1 2022.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Connable Office Inc's 13F filing for Q3 2023, filed 8 Nov 2023.